The top 10 core targets of YQWYF for DKD treatment were obtained by network pharmacology including TNF, IL6, AKT1, GAPDH, BCL2, ESR1, SRC, CTNNB1, EGFR, and PPARG. The gene discussed is AKT1; the disease is diabetic kidney disease.